Competitive Landscape by Indication
151 indications, 102,602 trials mapped
Oncology
40,168 trialsSolid Tumor (Advanced)
6434 trials
541 Ph3
Merck, Eli Lilly, Sichuan Baili Pharmaceutical Co., Ltd.
Breast Cancer
2555 trials
445 Ph3
AstraZeneca, Roche, Pfizer
Non-Hodgkin Lymphoma
2547 trials
223 Ph3
Roche, Genmab, Merck
NSCLC
2462 trials
395 Ph3
AstraZeneca, Merck, Roche
ALL
1949 trials
293 Ph3
Novartis, Pfizer, AstraZeneca
Colorectal Cancer
1815 trials
247 Ph3
AstraZeneca, AbbVie, Revolution Medicines, Inc.
Prostate Cancer
1621 trials
250 Ph3
Novartis, Johnson & Johnson, AstraZeneca
AML
1269 trials
118 Ph3
AbbVie, Taiho Oncology, Inc., Kura Oncology, Inc.
Multiple Myeloma
1211 trials
143 Ph3
Johnson & Johnson, GSK, AbbVie
Pancreatic Cancer
1136 trials
106 Ph3
Revolution Medicines, Inc., AstraZeneca, Seagen, a wholly owned subsidiary of Pfizer
Melanoma
1081 trials
99 Ph3
Merck, Bristol-Myers Squibb, Novartis
Hepatocellular Carcinoma
1016 trials
146 Ph3
AstraZeneca, Roche, Akeso
Hematologic Malignancies
994 trials
86 Ph3
Johnson & Johnson, Novartis, Orca Biosystems, Inc.
Ovarian Cancer
988 trials
117 Ph3
AstraZeneca, AbbVie, Merck
Head and Neck Cancer
948 trials
78 Ph3
Sichuan Baili Pharmaceutical Co., Ltd., AstraZeneca, Pfizer
Lung Cancer (General)
934 trials
121 Ph3
Chongqing Precision Biotech Co., Ltd, AstraZeneca, Avistone Biotechnology Co., Ltd.
Sarcoma
900 trials
63 Ph3
Eli Lilly, Hansoh BioMedical R&D Company, Philogen S.p.A.
Bladder Cancer
833 trials
123 Ph3
Merck, AstraZeneca, Pfizer
Gastric Cancer
815 trials
120 Ph3
AstraZeneca, Astellas Pharma Global Development, Inc., Chongqing Precision Biotech Co., Ltd
MDS
719 trials
58 Ph3
Bristol-Myers Squibb, Takeda, Taiho Oncology, Inc.
Esophageal Cancer
717 trials
116 Ph3
AstraZeneca, Merck, AbbVie
Glioblastoma
637 trials
45 Ph3
Novartis, Philogen S.p.A., Telix Pharmaceuticals (Innovations) Pty Limited
Brain Tumor
628 trials
51 Ph3
Jazz Pharmaceuticals, Pfizer, InSightec
SCLC
551 trials
76 Ph3
Amgen, AstraZeneca, Boehringer Ingelheim
Renal Cell Carcinoma
547 trials
51 Ph3
Merck, Bristol-Myers Squibb, Exelixis
Triple Negative Breast Cancer
526 trials
56 Ph3
Gilead, Novartis, Eli Lilly
Squamous Cell Carcinoma
501 trials
48 Ph3
Regeneron, Ankyra Therapeutics, Inc, Alentis Therapeutics AG
Hodgkin Lymphoma
494 trials
31 Ph3
Merck, AbbVie, Sichuan Baili Pharmaceutical Co., Ltd.
Cholangiocarcinoma
473 trials
45 Ph3
AstraZeneca, Suzhou Suncadia Biopharmaceuticals Co., Ltd., Eli Lilly
Cervical Cancer
445 trials
73 Ph3
AstraZeneca, Shanghai Bovax Biotechnology Co., Ltd., Merck
CLL
435 trials
49 Ph3
BeOne Medicines, AbbVie, Ascentage Pharma Group Inc.
Neuroendocrine Tumors
403 trials
79 Ph3
Vertex Pharmaceuticals Incorporated, Quoin Pharmaceuticals, ITM Solucin GmbH
Endometrial Cancer
370 trials
43 Ph3
AstraZeneca, Genmab, Merck
Myelofibrosis
233 trials
31 Ph3
Novartis, Bristol-Myers Squibb, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Mesothelioma
219 trials
14 Ph3
Novartis, NGM Biopharmaceuticals, Inc, Seagen, a wholly owned subsidiary of Pfizer
CML
209 trials
19 Ph3
Novartis, Shenzhen TargetRx, Inc., Jiangsu Hansoh Pharmaceutical Co., Ltd.
Thyroid Cancer
170 trials
25 Ph3
Eli Lilly, Exelixis, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
HER2+ Breast Cancer
151 trials
31 Ph3
Sichuan Baili Pharmaceutical Co., Ltd., Jazz Pharmaceuticals, Roche
HER2- Breast Cancer
143 trials
16 Ph3
AstraZeneca, BeiGene, Olema Pharmaceuticals, Inc.
Merkel Cell Carcinoma
89 trials
6 Ph3
TuHURA Biosciences, Inc., ImmunityBio, Inc., Neonc Technologies, Inc.
Immunology
20,819 trialsRheumatoid Arthritis
9130 trials
2092 Ph3
AstraZeneca, Novartis, AbbVie
Ankylosing Spondylitis
7644 trials
1673 Ph3
Eli Lilly, AstraZeneca, Novartis
Ulcerative Colitis
1264 trials
273 Ph3
Takeda, AbbVie, Eli Lilly
Lupus
864 trials
157 Ph3
Novartis, AstraZeneca, Bristol-Myers Squibb
Psoriasis
653 trials
217 Ph3
Johnson & Johnson, Bristol-Myers Squibb, UCB Biopharma SRL
Atopic Dermatitis
641 trials
175 Ph3
Pfizer, AbbVie, Keymed Biosciences Co.Ltd
Crohn's Disease
335 trials
98 Ph3
Takeda, Johnson & Johnson, AbbVie
Psoriatic Arthritis
145 trials
56 Ph3
UCB Biopharma SRL, AbbVie, Eli Lilly
IBD
143 trials
20 Ph3
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company), SinoMab BioScience Ltd, Mirador Therapeutics, Inc.
Cardiovascular
8,658 trialsMyocardial Infarction
4239 trials
1003 Ph3
AstraZeneca, Novartis, Bristol-Myers Squibb
Atrial Fibrillation
1096 trials
215 Ph3
Incyte Corporation, Novartis, Sanofi
Hypertension
1054 trials
299 Ph3
Boryung Pharmaceutical Co., Ltd, Addpharma Inc., Merck
Stroke
756 trials
277 Ph3
Tisento Therapeutics, Beijing Suncadia Pharmaceuticals Co., Ltd, Shin Poong Pharmaceutical Co. Ltd.
Heart Failure
752 trials
164 Ph3
Novo Nordisk, Help Therapeutics, AstraZeneca
Coronary Artery Disease
481 trials
88 Ph3
Novartis, XyloCor Therapeutics, Inc., Sinotau Pharmaceutical Group
Thrombosis
170 trials
67 Ph3
Regeneron, Boston Scientific Corporation, Anthos Therapeutics, Inc.
Arrhythmia
61 trials
18 Ph3
Cardurion Pharmaceuticals, Inc., Solid Biosciences Inc., Agiana Pharmaceuticals
Hypertrophic Cardiomyopathy
49 trials
17 Ph3
Shandong Suncadia Medicine Co., Ltd., Cytokinetics, Bristol-Myers Squibb
CNS
6,711 trialsMajor Depression
1017 trials
249 Ph3
Neurocrine Biosciences, Johnson & Johnson, Neumora Therapeutics, Inc.
Alzheimer's Disease
977 trials
188 Ph3
Eli Lilly, Bristol-Myers Squibb, Roche
Multiple Sclerosis
778 trials
188 Ph3
Roche, Novartis, Sanofi
Parkinson's Disease
564 trials
80 Ph3
iRegene Therapeutics Co., Ltd., Luye Pharma Group Ltd., Roche
Schizophrenia
431 trials
117 Ph3
Neurocrine Biosciences, Luye Pharma Group Ltd., Bristol-Myers Squibb
Opioid Use Disorder
367 trials
73 Ph3
Go Medical Industries Pty Ltd, Akyso Therapeutics, LLC, Boehringer Ingelheim
ALS
356 trials
80 Ph3
Amylyx Pharmaceuticals Inc., Biogen, Novartis
Migraine
347 trials
157 Ph3
AbbVie, Pfizer, H. Lundbeck A/S
Epilepsy
295 trials
89 Ph3
UCB Biopharma SRL, Xenon Pharmaceuticals Inc., SK Life Science, Inc.
Alcohol Use Disorder
279 trials
42 Ph3
Eli Lilly, Afasci Inc, Pop Test Oncology LLC
Anxiety
263 trials
52 Ph3
VistaGen Therapeutics, Inc., Beijing Union Pharmaceutical Factory Ltd, Definium Therapeutics US, Inc.
Neuropathy
240 trials
67 Ph3
argenx, Sanofi, Takeda
Autism Spectrum Disorder
215 trials
44 Ph3
Intra-Cellular Therapies, Inc., MapLight Therapeutics, Bristol-Myers Squibb
PTSD
185 trials
37 Ph3
Oui Therapeutics, Inc., Senseye, Inc., Otsuka Medical Devices Co., Ltd. Japan
ADHD
161 trials
65 Ph3
Otsuka Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc., Boehringer Ingelheim
Bipolar Disorder
130 trials
40 Ph3
Intra-Cellular Therapies, Inc., Bristol-Myers Squibb, Xenon Pharmaceuticals Inc.
Huntington's Disease
55 trials
9 Ph3
Roche, Novartis, Skyhawk Therapeutics, Inc.
OCD
51 trials
6 Ph3
Vericel Corporation, Biohaven Pharmaceuticals, Inc.
Infectious Disease
6,555 trialsCOVID-19
2232 trials
739 Ph3
BioNTech SE, Novavax, ModernaTX, Inc.
HIV
1195 trials
222 Ph3
ViiV Healthcare, Gilead, Merck
Influenza
705 trials
175 Ph3
GSK, Sanofi, Valenta Pharm JSC
Hepatitis B
390 trials
43 Ph3
GSK, Ausper Biopharma Co., Ltd., Beijing Continent Pharmaceutical Co, Ltd.
Malaria
340 trials
65 Ph3
Sanaria Inc., GSK, Novartis
Sepsis
335 trials
104 Ph3
Bayer, ImmunityBio, Inc., Tianjin Chasesun Pharmaceutical Co., LTD
Hepatitis C
324 trials
107 Ph3
Atea Pharmaceuticals, Inc., Gilead, AbbVie
Tuberculosis
297 trials
82 Ph3
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., Shanghai Jiatan Pharmatech Co., Ltd, Otsuka Pharmaceutical Development & Commercialization, Inc.
RSV
247 trials
65 Ph3
GSK, ModernaTX, Inc., Sanofi
H. pylori
157 trials
33 Ph3
ARJ Medical, Inc., Catalysis SL, TenNor Therapeutics (Suzhou) Limited
Fungal Infections
124 trials
33 Ph3
Mundipharma Research Limited, F2G Biotech GmbH, Basilea Pharmaceutica
C. difficile
110 trials
29 Ph3
Vedanta Biosciences, Inc., AstraZeneca, Theriva Biologics, Inc.
Bacterial Infections
99 trials
16 Ph3
Pfizer, Qpex Biopharma, Inc., CanSino Biologics Inc.
Metabolic
5,083 trialsType 2 Diabetes
1328 trials
375 Ph3
Eli Lilly, Novo Nordisk, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Obesity
1140 trials
262 Ph3
Eli Lilly, Novo Nordisk, Amgen
Diabetes (General)
832 trials
189 Ph3
Gan & Lee Pharmaceuticals., Jiangsu HengRui Medicine Co., Ltd., EMS
NASH/NAFLD
491 trials
55 Ph3
GSK, Akero Therapeutics, Inc, Madrigal Pharmaceuticals, Inc.
Type 1 Diabetes
465 trials
95 Ph3
Eli Lilly, Sanofi, Novo Nordisk
Dyslipidemia
455 trials
170 Ph3
Addpharma Inc., Novartis, Qilu Pharmaceutical Co., Ltd.
Diabetic Complications
372 trials
83 Ph3
Roche, EyeBiotech Ltd., Novartis
Pain
2,745 trialsAcute Pain
1611 trials
425 Ph3
Shanghai Haiyan Pharmaceutical Technology Co., Ltd., Eli Lilly, AFT Pharmaceuticals, Ltd.
Postoperative Pain
763 trials
161 Ph3
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd., Pacira Pharmaceuticals, Inc, Haisco Pharmaceutical Group Co., Ltd.
Chronic Pain
187 trials
43 Ph3
Evon Medics LLC, iN Therapeutics Co., Ltd., Sustained Therapeutics Inc.
Neuropathic Pain
184 trials
33 Ph3
Vertex Pharmaceuticals Incorporated, Eli Lilly, Haisco Pharmaceutical Group Co., Ltd.
Respiratory
2,402 trialsAsthma
702 trials
207 Ph3
AstraZeneca, GSK, Sanofi
COPD
538 trials
124 Ph3
AstraZeneca, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., GSK
Pneumonia
489 trials
155 Ph3
GSK, Avidity Biosciences, Inc., Qilu Pharmaceutical Co., Ltd.
Cystic Fibrosis
304 trials
80 Ph3
Vertex Pharmaceuticals Incorporated, Sionna Therapeutics Inc., Boehringer Ingelheim
Idiopathic Pulmonary Fibrosis
226 trials
37 Ph3
Boehringer Ingelheim, Bristol-Myers Squibb, Guangdong Hengrui Pharmaceutical Co., Ltd
Allergic Rhinitis
143 trials
53 Ph3
Genrix (Shanghai) Biopharmaceutical Co., Ltd., Prime Gene Therapeutics Co., Ltd., ALK-Abelló A/S
Urology
2,388 trialsErectile Dysfunction
2135 trials
500 Ph3
AstraZeneca, Novartis, Nanjing Leads Biolabs Co.,Ltd
Overactive Bladder
183 trials
44 Ph3
Levee Medical, Inc., Cook MyoSite, TBF Genie Tissulaire
Benign Prostatic Hyperplasia
70 trials
20 Ph3
Addpharma Inc., Resurge Therapeutics Inc., Chong Kun Dang Pharmaceutical
Musculoskeletal
1,319 trialsOsteoarthritis
931 trials
248 Ph3
Eli Lilly, Pacira Pharmaceuticals, Inc, UCB Biopharma SRL
Osteoporosis
192 trials
48 Ph3
Amgen, Qilu Pharmaceutical Co., Ltd., Shenzhen Salubris Pharmaceuticals Co., Ltd.
Gout
155 trials
28 Ph3
Arthrosi Therapeutics, Jiangsu HengRui Medicine Co., Ltd., Atom Therapeutics Co., Ltd
Muscle Spasm
41 trials
13 Ph3
Chongqing Claruvis Pharmaceutical Co., Ltd., RVL Pharmaceuticals, Inc., Ipsen
Rare Disease
1,256 trialsSpinal Muscular Atrophy
339 trials
84 Ph3
Roche, Wuhan Createrna Science and Technology Co., Ltd, Novartis
Immune Thrombocytopenia
257 trials
80 Ph3
Novartis, Jiangsu HengRui Medicine Co., Ltd., argenx
Sickle Cell Disease
256 trials
57 Ph3
Novartis, Novo Nordisk, Vertex Pharmaceuticals Incorporated
Hemophilia
198 trials
79 Ph3
Pfizer, Roche, CSL Behring
Duchenne Muscular Dystrophy
114 trials
25 Ph3
NS Pharma, Inc., Italfarmaco, Solid Biosciences Inc.
Fabry Disease
39 trials
21 Ph3
Chiesi Farmaceutici S.p.A., Amicus Therapeutics, Sanofi
Gaucher Disease
28 trials
5 Ph3
Spur Therapeutics, Prevail Therapeutics, Genzyme, a Sanofi Company
Mastocytosis
20 trials
2 Ph3
Blueprint Medicines Corporation, Cogent Biosciences, Inc., MacroGenics
CDKL5 Deficiency Disorder
5 trials
3 Ph3
Zogenix, Inc., Immedica Pharma AB, Marinus Pharmaceuticals
Ophthalmology
918 trialsGastrointestinal
887 trialsPeptic Ulcer
341 trials
82 Ph3
Johnson & Johnson, Sanofi, Cellution Biologics
Nausea/Vomiting
224 trials
67 Ph3
Helsinn Healthcare SA, Eli Lilly, Vanda Pharmaceuticals
Constipation
130 trials
40 Ph3
Ardelyx, Shionogi, HK inno.N Corporation
Diarrhea
125 trials
27 Ph3
Crinetics Pharmaceuticals Inc., Tasly Pharmaceutical Group Co., Ltd, Vedanta Biosciences, Inc.
GERD
67 trials
14 Ph3
Cinclus Pharma Holding AB, Takeda, Addpharma Inc.
Renal
792 trialsWomen's Health
657 trialsInfertility
256 trials
86 Ph3
IBSA Institut Biochimique SA, Qilu Pharmaceutical Co., Ltd., Fertility Center of Las Vegas
Menopause
131 trials
32 Ph3
Bayer, Astellas Pharma Global Development, Inc., Astellas Pharma Inc
PCOS
128 trials
37 Ph3
Wellizen Australia, Fujian Shengdi Pharmaceutical Co., Ltd., PT. Prodia Stem Cell Indonesia
Endometriosis
111 trials
32 Ph3
Kissei Pharmaceutical Co., Ltd., AbbVie, Hope Medicine (Nanjing) Co., Ltd
Contraception
31 trials
8 Ph3
YourChoice Therapeutics, Inc., Mylan Pharmaceuticals Inc, Next Life Sciences
Dermatology
588 trialsAcne
229 trials
73 Ph3
Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd., Sanofi, AbbVie
Alopecia
197 trials
50 Ph3
Pfizer, Applied Biology, Inc., Veradermics, Inc.
Vitiligo
78 trials
19 Ph3
Incyte Corporation, Pfizer, Jiangsu HengRui Medicine Co., Ltd.
Rosacea
70 trials
20 Ph3
Tarsus Pharmaceuticals, Inc., Sol-Gel Technologies, Ltd., Vyne Therapeutics Inc.
Skin Infections
14 trials
3 Ph3
AbbVie, UNION therapeutics
Hepatology
279 trialsSleep
236 trialsEndocrine
141 trialsGrowth Hormone Deficiency
53 trials
25 Ph3
Changchun GeneScience Pharmaceutical Co., Ltd., Lumos Pharma, Novo Nordisk
Hypothyroidism
27 trials
8 Ph3
AbbVie, IBSA Institut Biochimique SA, Neuvosyn Laboratories, LLC
Acromegaly
26 trials
8 Ph3
Crinetics Pharmaceuticals Inc., Debiopharm International SA, AstraZeneca
Hyperthyroidism
19 trials
4 Ph3
Biohaven Therapeutics Ltd., Merida Biosciences, Changchun GeneScience Pharmaceutical Co., Ltd.
Adrenal Insufficiency
16 trials
3 Ph3
Neurocrine UK Limited
Click any indication to see full competitive landscape (all sponsors, trials, phases).
Data: ClinicalTrials.gov | Mapping: Indication Taxonomy